Literature DB >> 12645804

No additive effect between Helicobacter pylori infection and portal hypertensive gastropathy on inducible nitric oxide synthase expression in gastric mucosa of cirrhotic patients.

Usama A Arafa1, Yasuhiro Fujiwara, Kazuhide Higuchi, Masatsugu Shiba, Toshiyuki Uchida, Toshio Watanabe, Kazunari Tominaga, Nobuhide Oshitani, Takayuki Matsumoto, Tetsuo Arakawa.   

Abstract

Increased expression of inducible nitric oxide synthase (iNOS) has been reported in gastric mucosa of patients with Helicobacter pylori infection or portal hypertensive gastropathy (PHG) but whether there is an additive or synergistic impact between H. pylori and PHG on iNOS expression was unknown. Sixty cirrhotic patients and 21 age-matched control subjects without liver disease were included. Biopsies from the gastric antrum and body were obtained for quantitative histological assessment and immunohistochemical staining for iNOS. iNOS staining was detected in endothelial cells and macrophages. In the absence of PHG, H. pylori significantly induced iNOS expression in cirrhotic patients. PHG also significantly induced iNOS expression in H. pylori-negative patients. However, there was no synergistic or additive effect between H. pylori and PHG on this expression. Furthermore, expression of iNOS was significantly higher in patients with severe PHG than in those with mild PHG and without PHG.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645804     DOI: 10.1023/a:1021707103590

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Induction of caspase-3 and nitric oxide synthase-2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide.

Authors:  B L Slomiany; J Piotrowski; A Slomiany
Journal:  Biochem Mol Biol Int       Date:  1998-12

2.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

3.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages.

Authors:  S S Gross; E A Jaffe; R Levi; R G Kilbourn
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

4.  The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver.

Authors:  K K Balan; A T Jones; N B Roberts; J P Pearson; M Critchley; S A Jenkins
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

Review 5.  Helicobacter pylori and the pathogenesis of gastroduodenal inflammation.

Authors:  M J Blaser
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

6.  Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line.

Authors:  K T Wilson; K S Ramanujam; H L Mobley; R F Musselman; S P James; S J Meltzer
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

7.  Enhanced expression of inducible nitric oxide synthase in chronic gastritis with intestinal metaplasia.

Authors:  M Tatemichi; T Ogura; H Nagata; H Esumi
Journal:  J Clin Gastroenterol       Date:  1998-10       Impact factor: 3.062

Review 8.  Helicobacter pylori and the liver: any relationship?

Authors:  F Farinati; M De Bona; A Floreani; F Foschia; M Rugge
Journal:  Ital J Gastroenterol Hepatol       Date:  1998-02

9.  Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.

Authors:  H M El-Newihi; V K Kanji; A A Mihas
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

10.  Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-alpha, and hyperdynamic circulation.

Authors:  F Y Lee; R H Lu; Y T Tsai; H C Lin; M C Hou; C P Li; T M Liao; L F Lin; S S Wang; S D Lee
Journal:  Scand J Gastroenterol       Date:  1996-05       Impact factor: 2.423

View more
  4 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

2.  Helicobacter pylori infection in patients with liver cirrhosis: prevalence and association with portal hypertensive gastropathy.

Authors:  Shanid Abdul Sathar; Sojan George Kunnathuparambil; Srijaya Sreesh; Premaletha Narayanan; Kattoor Ramakrishnan Vinayakumar
Journal:  Ann Gastroenterol       Date:  2014

3.  Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels.

Authors:  Zaigham Abbas; Javed Yakoob; Muhammad W Usman; Tanzila Shakir; Saeed Hamid; Wasim Jafri
Journal:  Saudi J Gastroenterol       Date:  2014 Mar-Apr       Impact factor: 2.485

4.  Helicobacter pylori infection is not associated with portal hypertension-related gastrointestinal complications: A meta-analysis.

Authors:  Yu Kyung Jun; Ji Won Kim; Byeong Gwan Kim; Kook Lae Lee; Yong Jin Jung; Won Kim; Hyun Sun Park; Dong Hyeon Lee; Seong-Joon Koh
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.